As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs Ryan Hogg Fortune 10 1 05.02.2025 Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.© Fortune visit website